By Matt Skoufalos
Wayne Moore, CEO of Acertara Acoustic Laboratories of Longmont, Colorado has been re-elected as the Ultrasound Section Chair for the Medical Imaging and Technology Alliance (MITA), a division of the National Electrical Manufacturers Association (NEMA). Moore, an ex-officio member of the MITA Board of Directors, also co-chairs the Output Standards Committee for the American Institute of Ultrasound in Medicine (AIUM).
Biocoat, Inc. of Horsham, Pennsylvania added Steven Bell as CFO. Bell has been a middle-market CFO consultant and senior executive for companies like ReSearch Pharmaceutical Services, CareScience, and The MRC Group. Bell is treasurer and board member of the nonprofit Shamrock Reins, and a member of the American and Pennsylvania Institutes of Certified Public Accountants, Pennsylvania Bio, Alliance of Merger & Acquisition Advisors, and The Greater Philadelphia Alliance for Capital and Technologies (PACT).
Functional Neuromodulation Ltd. of Minneapolis, Minnesota has named Todd Langevin as its CEO, succeeding Vincent Owens, who will remain as its executive chairman. Langevin was FNM president and COO since its formation in 2011, and has held senior leadership roles at CVRx and Medtronic.
Canopy Health of Emeryville, California has named Mike Robinson its new CEO. Robinson, a longtime Aetna executive, former chair of the John Muir Health Board of Directors, and a current Canopy Health board member, succeeds outgoing CEO Joel Criste.
Cardinal Health of Dublin, Ohio named Brian Rice as its EVP of customer support services and chief information officer (CIO). Rice was most recently SVP of global business services and CIO for Kellogg Company, has been global services information officer of General Motors Corporation, and has been VP and CIO for Mars, Inc.
The Pasadena, California-based Huntington Hospital has named Harry Fisk Bowles its chief of medical staff. Bowles holds a master’s degree in science from the University of California, Davis and his medical degree from the University of Southern California (USC). He is a diplomate of The American Board of Addiction Medicine.
Health Alliance Plan (HAP) of Detroit, Michigan has added John Gorman and Jeff Chaffkin to the HAP Board of Directors. Gorman is the founder and former executive chairman at Gorman Health Group (GHG), was assistant to the director of Health Care Financing Administration’s Office of Managed Care, and served as the external liaison for the Medicare and Medicaid managed care programs. Chaffkin is senior healthcare advisor to XMS Capital Partners, previously served as a portfolio manager at Charter Oak Partners, and also was CFO of the health business unit of Aetna Health Plans and VP of planning and business development for Aetna International. He also was a managing director and U.S. pharmaceutical analyst at UBS in New York.
Sheppard Pratt Health System of Baltimore, Maryland named Laura Lawson Webb its VP and chief nursing officer and Jennifer Weiss Wilkerson as VP and chief strategy officer. Webb, who previously was manager of patient care services and a teacher at Vanderbilt, takes over for the retiring Ernestine Cosby. Prior to joining Sheppard Pratt, Wilkerson was VP of regional planning for MedStar Health, VP of strategic planning, marketing, and business development for MedStar Good Samaritan Hospital, and holds a master’s degree in Health Services Administration from George Washington University.
CentralReach of Pompano Beach, Florida added Cheryl Michael as its Chief Product Officer. Michael most recently was EVP of product management and engineering at Envera Health.
LeadingAge of Columbus, Ohio has added Ohio Living CEO Laurence C. Gumina to its board of directors. Gumina also serves on the board for the Presbyterian Association of Homes and Services for the Aging (PAHSA), and is on the investment committee for the Ziegler Link-Age Longevity Fund I & II. Gumina is also the Board Vice Chair for Link-Age and serves on the LeadingAge Ohio board of directors.
Maven of New York, New York has named Melissa Frieswick as its Chief Revenue Officer. Frieswick was most recently SVP of Sales at Virgin Pulse.
DCS Global of Dallas, Texas named Dominick DeRosa as its Chief Growth Officer. DeRosa most recently was SVP of Commercial Strategy and Partnerships at nThrive, has been a Sales Leader for CareMedic (Optum), and spent 17 years with HBOC (McKesson).
Craig Hospital of Englewood, Colorado has named Daniel Frank its new CFO, replacing the retiring Julie Keegan. Frank was most recently CFO of the Centura Health Longmont United Hospital, and has been the Director of Accounting and Reimbursement for Exempla Healthcare. He holds a master’s degree in Healthcare Administration from the University of Colorado Denver.
Service Corporation International (SCI) of Houston, Texas will see its president and COO Michael R. Webb retire on March 31, 2019. SCI Chairman and CEO Thomas L. Ryan will assume the title of president, and its SVP of Operations, Sumner J. Waring, III, will assume the role of COO, effective April 1, 2019.
Caris Life Sciences of Irving, Texas has named Srikant Ramaswami its VP and Chief Communications Officer. Ramaswami has 20 years of healthcare experience at Merck & Co., Inc., Pfizer Inc., and Johnson & Johnson. He joins Caris from rbb Communications, where he was most recently EVP for healthcare, and holds J.D. and M.S. degrees from the University at Buffalo School of Law and Columbia University.
Women’s Care Enterprises of Tampa, Florida has named Katy Eldridge its integration management officer. Eldridge joins the company from DuPage Medical Group and holds a bachelor’s degree in health care leadership from the University of St. Francis.
Nova Medical Centers of Houston, Texas has made Mark Thomet its SVP of inside sales. Thomet has been national VP of client retention, divisional VP of sales, regional VP of sales and regional sales director at U.S. Healthworks.
Amneal Pharmaceuticals, Inc. of Bridgewater, New Jersey named Todd P. Branning its SVP and CFO. Branning succeeds Bryan Reasons, who will remain with the company through the end of February 2019. He brings more than 25 years of experience in pharmaceuticals finance and accounting, and was most recently SVP and CFO for Teva Pharmaceuticals’ global generic medicines division.
Prime Therapeutics of Eagan, Minnesota added Sid Sahni as its new SVP of Chief Strategy and Corporate Development Officer. Sahni has more than 20 years of experience in health care and pharmacy benefits management, and most recently was VP of enterprise strategy at Aetna. He also spent eight years at CVS Health, and was a strategy consultant in the healthcare practice at Strategy& and BCG. Sahni has an MBA from the University of Michigan.